Essink Brandon - Meridian Clinical Research Omaha

基本信息

浏览量：7

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 67 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety and Immunogenicity of an Optimized Self-Replicating RNA Platform for Low Dose or Single Dose Vaccine Applications: a Randomized, Open Label Phase I Study in Healthy Volunteers

Christian J. Maine,Shigeki J. Miyake-Stoner,Darina S. Spasova,Gaelle Picarda, Annie C. Chou, Emily D. Brand, Melanie D. Olesiuk, Christine C. Domingo, Hunter J. Little, Thomas T. Goodman, Jacqueline L. Posy, Jasmin Gonzalez, Terrina L. Bayone,Jessica Sparks,Ebony N. Gary, Zhi Xiang,Nicholas J. Tursi, Casey E. Hojecki,Hildegund C. J. Ertl,David B. Weiner, Irafasha C. Casmil,Anna K. Blakney,Brandon Essink, Guillermo Somodevilla,Nathaniel S. Wang, Andrew J. Geall,Zelanna Goldberg,Parinaz Aliahmad

NATURE COMMUNICATIONSno. 1 (2025)

引用0浏览0WOSNATURE引用

An Mrna-Based Seasonal Influenza Vaccine in Adults: Results of Two Phase 3 Randomized Clinical Trials and Correlate of Protection Analysis of Hemagglutination Inhibition Titers

Boris Kandinov, Mieke Soens, Wenmei Huang, Conrado Llapur, David Ensz,Brandon Essink, Carlos Fierro, Jignesh Vakil, Alicia Pucci, Jia Guo, Sinead Rudden, Kristi Hall, Bryony Hicks, Kristin Schaefers, Honghong Zhou, Chong Ma, Lingyi Zheng,Andrei Avanesov,Yoonyoung Park, Evelyn Du,Jacqueline Miller,Jintanat Ananworanich, Raffael Nachbagauer

Human vaccines & immunotherapeuticsno. 1 (2025): 2484088-2484088

引用0浏览0WOS引用

Vaccine Efficacy of NVX-CoV2373 Against SARS-CoV-2 Infection in Adolescents in the USA: an Ancillary Study to a Phase 3, Observer-Blinded, Randomised, Placebo-Controlled Trial

Meagan E Deming,Elizabeth R Brown,Monica A McArthur, Stephanie J Schrag,Melissa Arvay,Mike Humphrys,Jacques Ravel,Jeffrey Adelglass,Brandon Essink, David B Musante, Rebecca Maguire,Richard Gorman, Elizabeth Formentini, Robin Mason,Merlin L Robb, Kathleen M Neuzil, Rekha R Rapaka, Peter Wolff,Karen L Kotloff

The Lancet Microbepp.100984, (2025)

引用0浏览0WOS引用

Comparative Assessment of Immunogenicity and Safety of Recombinant Influenza Vaccine in Children, Adolescents, and Adults: Results from a Phase 3, Immunobridging, Open-Label, Non-Randomised Study

Pedro M Folegatti, Stephanie Pepin,Cynthia Tabar, Katherine Fries,Oxana Talanova, Stephanie See,Brandon Essink, Todd Bertoch, Daniel Drazan, Silvina Natalini Martínez, Marek Konieczny, Kathleen Kaas-Leach, Iris De Bruijn

The Lancet Infectious diseases (2025)

引用0浏览0WOS引用

Long-term Safety and Effectiveness of Mrna-1273 Vaccine in Adults: COVE Trial Open-Label and Booster Phases